Truist Financial’s Silk Road Medical, Inc. Common Stock SILK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-5,426
Closed -$231K 2888
2021
Q4
$231K Sell
5,426
-259
-5% -$13K ﹤0.01% 2514
2021
Q3
$313K Sell
5,685
-3,111
-35% -$163K ﹤0.01% 2324
2021
Q2
$421K Sell
8,796
-12,241
-58% -$624K ﹤0.01% 2182
2021
Q1
$1.07M Buy
21,037
+10,330
+96% +$574K ﹤0.01% 1556
2020
Q4
$675K Buy
10,707
+849
+9% +$52.7K ﹤0.01% 1710
2020
Q3
$663K Buy
9,858
+148
+2% +$8.08K ﹤0.01% 1578
2020
Q2
$407K Buy
+9,710
New +$373K ﹤0.01% 1741

Other funds holding SILK

Truist Financial's SILK Position: Q1 2022 in Review

Truist Financial sold out of Silk Road Medical, Inc. Common Stock (SILK) in Q1 2022, closing a stake of 5,426 shares — an estimated $231K sold.

Truist Financial first reported a position in SILK in Q2 2020 and held it in 7 quarters. The position peaked at $1.07M in Q1 2021. 153 funds tracked by Wall St. Rank hold SILK as of Q1 2022.

  • Truist Financial reported no remaining Silk Road Medical, Inc. Common Stock position as of Q1 2022 after selling out during the quarter.
  • Truist Financial sold 5,426 Silk Road Medical, Inc. Common Stock shares in Q1 2022, an estimated $231K.
  • Truist Financial first reported a position in Silk Road Medical, Inc. Common Stock in Q2 2020 and held it in 7 quarters.
  • Truist Financial's Silk Road Medical, Inc. Common Stock position peaked at $1.07M in Q1 2021.
  • 153 funds tracked by Wall St. Rank held Silk Road Medical, Inc. Common Stock as of Q1 2022.

Based on Truist Financial's 13F filing for Q1 2022, filed 22 Apr 2022.